Dominique Bluteau

发表

P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1.

D. Bluteau, W. Vainchenker, N. Debili, 2008, Blood.

Regulation of megakaryocyte maturation and platelet formation

D. Bluteau, W. Vainchenker, N. Debili, 2009, Journal of thrombosis and haemostasis : JTH.

Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.

D. Bluteau, A. Balduini, N. Balayn, 2014, The Journal of clinical investigation.

Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression.

D. Bluteau, N. Balayn, P. Nurden, 2012, Blood.

From hematopoietic stem cells to platelets

D. Bluteau, W. Vainchenker, N. Debili, 2007, Journal of thrombosis and haemostasis : JTH.

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.

E. Gilson, F. Sigaux, J. Soulier, 2023, Cell stem cell.

Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.

D. Bluteau, N. Balayn, E. Solary, 2015, Blood.

Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia

D. Bluteau, N. Balayn, R. Favier, 2018, Haematologica.

MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.

D. Bluteau, C. Deswarte, G. Leverger, 2012, Blood.

Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets

D. Bluteau, H. Raslova, R. Laguens, 2014, Journal of thrombosis and haemostasis : JTH.

Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.

D. Bluteau, W. Vainchenker, N. Debili, 2011, Blood.

MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9.

D. Bluteau, W. Vainchenker, N. Debili, 2009, Blood.

Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes

D. Bluteau, F. Mami-Chouaib, G. Bismuth, 2014, The Journal of Immunology.

RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization

D. Bluteau, W. Vainchenker, N. Debili, 2012, Nature Communications.

Biallelic inactivation of REV7 is associated with Fanconi anemia.

J. Soulier, A. Baruchel, D. Bluteau, 2016, The Journal of clinical investigation.

LymphocytesInduce CD103 Expression in Human CD8 T Smad and NFAT Pathways Cooperate To

D. Bluteau, F. Mami-Chouaib, G. Bismuth, 2014 .

p19INK4d Controls Hematopoietic Stem Cells in a Cell-Autonomous Manner during Genotoxic Stress and through the Microenvironment during Aging

D. Bluteau, N. Balayn, W. Vainchenker, 2014, Stem cell reports.

Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia

J. Soulier, D. Bluteau, J. Surrallés, 2017, Genetics in Medicine.

OTT-MAL Is a Deregulated Activator of Serum Response Factor-Dependent Gene Expression

R. Treisman, A. Menssen, D. Bluteau, 2008, Molecular and Cellular Biology.

Amendment history : Corrigendum ( March 2017 ) Biallelic inactivation of REV 7 is associated with Fanconi anemia

J. Soulier, A. Baruchel, D. Bluteau, 2019 .